Write in a clean editor, then format for JNCI: Journal of the National Cancer Institute in one click — DocuGuru applies the official Oxford University Press template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
JNCI: Journal of the National Cancer Institute is a peer-reviewed journal published by Oxford University Press, covering Diverse Scientific and Economic Studies, Global Cancer Incidence and Screening, Human auditory perception and evaluation. Over its lifetime it has published 32,743 papers, which have received 1,580,231 citations.
| Publisher | Oxford University Press |
|---|---|
| Reference style | Numbered (OUP) Numbered — [1], [2] in the text [1] A. Smith, B. Jones, and C. Lee, A representative article title, JNCI: Journal of the National Cancer Institute 12 (2023) 45–58.
Formats any DOI in the closest standard style — JNCI: Journal of the National Cancer Institute has no published style definition, so this is an approximation. No sign-up. |
| Publishes research in | Diverse Scientific and Economic Studies Global Cancer Incidence and Screening Human auditory perception and evaluation Virus-based gene therapy research Breast Cancer Treatment Studies |
| ISSN | 0027-8874 |
| Citation impact (2-yr) | 4.21 |
| h-index | 491 |
| i10-index | 14,589 |
| Article processing charge | $4,978 |
| Top institutions publishing here | National Cancer Institute |
| Journal website | jnci.oxfordjournals.org |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
BACKGROUND: In 1986, the European Organization for Research and Treatment of Cancer (EORTC) initiated a research program to develop an integrated, modular approach for evaluating the quality of life of patients participating in international clinical trials. PURPOSE: We report here the results of an international field study of the practicality, reliability, and validity of the…
Anticancer cytotoxic agents go through a process by which their antitumor activity-on the basis of the amount of tumor shrinkage they could generate-has been investigated. In the late 1970s, the International Union Against Cancer and the World Health Organization introduced specific criteria for the codification of tumor response evaluation. In 1994, several organizations involved in…
The role and limitations of retrospective investigations of factors possibly associated with the occurrence of a disease are discussed and their relationship to forward-type studies emphasized. Examples of situations in which misleading associations could arise through the use of inappropriate control groups are presented. The possibility of misleading associations may be minimized by controlling or…
We have developed a rapid, sensitive, and inexpensive method for measuring the cellular protein content of adherent and suspension cultures in 96-well microtiter plates. The method is suitable for ordinary laboratory purposes and for very large-scale applications, such as the National Cancer Institute's disease-oriented in vitro anticancer-drug discovery screen, which requires the use of several…
BACKGROUND: The finding of a decrease in contralateral breast cancer incidence following tamoxifen administration for adjuvant therapy led to the concept that the drug might play a role in breast cancer prevention. To test this hypothesis, the National Surgical Adjuvant Breast and Bowel Project initiated the Breast Cancer Prevention Trial (P-1) in 1992. METHODS: Women…
